Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, Schwartz S, Steffen B, Spriewald B, Heinicke T, Jäkel N, Westermann J, Nachtkamp K, Viardot A, Topp MS, Neumann M, Baldus CD, Gökbuget N, Brüggemann M (2024)

Publication Language: English

Publication Type: Journal article, Letter

Publication year: 2024

Journal

Leukemia Springer Nature

DOI: 10.1038/s41375-024-02209-7

Authors with CRIS profile

Bernd Spriewald Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Universitätsklinikum Düsseldorf DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) Universitätsklinikum Würzburg DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Goethe-Universität Frankfurt am Main DE Germany (DE) Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Universitätsklinikum Halle (Saale) DE Germany (DE)

How to cite

APA:

Burmeister, T., Ströh, A.-S., Kehden, B., Trautmann, H., Meyer, C., Marschalek, R.,... Brüggemann, M. (2024). Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia. Leukemia. https://doi.org/10.1038/s41375-024-02209-7

MLA:

Burmeister, Thomas, et al. "Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia." Leukemia (2024).

BibTeX: Download